Modified on: Mon, 20 Aug, 2018 at 4:46 PM
Medicare requires data submission to an approved clinical practice registry as a condition for reimbursement for lung cancer screening exams. The ACR Lung Cancer Screening Registry (LCSR) is approved by CMS for this purpose.
As a CMS-approved lung cancer screening clinical practice registry, we require data to be submitted on all patients who undergo screening at your facility. We will provide participating facilities with facility-level and physician-level reports that contain comparisons between you and your peers on measures of interpretive quality. We will submit data to CMS data requested by them to validate registry participation.
Yes. The new facility registration form can be used by facilities, physician groups or other entities to register the locations at which you practice. If this is the first time your group is registering any of the sites where it practices, will first apply for a corporate account ID and then register each physical location within that account. See The Application Process for details.
Lung Cancer Screening Registry
ACR Lung Cancer Screening Center Designation
Required for CMS reimbursement
Available to all facilities
Registration starting May 2015
Data submission: Summer 2015
Available to all facilities that have achieved ACR CT
Accreditation in at least the chest module
Dependent upon number of radiologists and sites involved
$400 per facility
Collect required data elements for submission to the registry interface
Mail or fax application, signed attestation, completed clinical data form with lung cancer screening protocol (based on average-size patient study) and fee
The ACR Lung Cancer Screening Registry is approved by the Center for Medicare and Medicaid Services to enable providers to meet quality reporting requirements to receive Medicare CT lung cancer screening payment.
The ACR Lung Cancer Screening Center Designation makes your site notable as a provider of safe, effective diagnostic care for those considered at high risk for lung cancer.
No. We do, however, require a patient ID that uniquely identifies each patient within your facility. It is important to note that without the Medicare beneficiary ID, we will be unable to document your compliance with the CMS reimbursement requirement to submit low-dose CT lung cancer screening data to a registry.
Yes. Documenting compliance with CMS reimbursement requirements is only one of the purposes of the LCSR. It primarily serves as a quality improvement tool for studying the benefits of low-dose CT lung cancer screening. By signing the LCSR participation agreement, you agree to report all low-dose CT lung cancer screening exams. However, you should not report data on participants of studies or clinical trials whose Institutional Review Board (IRB) has expressly prohibited such reporting.
In order for CMS to approve the LCSR for meeting quality reporting requirements for reimbursement, the ACR submitted an application demonstrating the LCSR’s value for the assessment of quality of low-dose CT lung cancer screening. A panel of experts from the LCSR Committee determined which data elements would be essential for monitoring the quality of low-dose CT lung cancer screening. Because screening is performed on an asymptomatic population, there is an added responsibility for the medical community to ensure that risks and benefits are adequately measured and monitored. The additional data elements are essential for monitoring quality and ensuring that the benefits of screening in clinical practice meet or exceed the benefits found in research.
You can submit data to the LCSR according to your schedule; however, we suggest that you submit data monthly.
The time at which you bill for either component is entirely up to your workflow; however, it is assumed that you have submitted the low-dose CT exam data to the registry first.
We send quarterly reports to CMS that detail the exam information provided to us during your data submission.
For the purposes of reporting to the LCSR data registry, your facility or group of radiologists should provide Lung-RADS Assessment Categories to the registry. We strongly recommend including the Lung-RADS Assessment in the radiologist’s final report, so it can be provided to the registry.
Did you find it helpful?
Sorry we couldn't be helpful. Help us improve this article with your feedback.